RHJA
HRMY icon

Rice Hall James & Associates’s Harmony Biosciences HRMY Stock Holding History

Rice Hall James & Associates’s Portfolio HRMY Stock Details HRMY Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2025
Q3 		– Sell
-76,287
Closed -$2.41M – 254
2025
Q2 		$2.41M Sell
76,287
-285
-0.4% -$9.17K 0.13% 149
2025
Q1 		$2.54M Sell
76,572
-178
-0.2% -$6.38K 0.15% 139
2024
Q4 		$2.64M Sell
76,750
-2,521
-3% -$86.6K 0.15% 153
2024
Q3 		$3.17M Sell
79,271
-1,241
-2% -$43.6K 0.17% 134
2024
Q2 		$2.43M Buy
80,512
+23,867
+42% +$718K 0.15% 145
2024
Q1 		$1.9M Sell
56,645
-10,709
-16% -$344K 0.11% 178
2023
Q4 		$2.18M Sell
67,354
-33,740
-33% -$942K 0.13% 165
2023
Q3 		$3.31M Sell
101,094
-1,456
-1% -$50.5K 0.21% 112
2023
Q2 		$3.61M Sell
102,550
-17,942
-15% -$619K 0.2% 114
2023
Q1 		$3.93M Buy
120,492
+38,174
+46% +$1.74M 0.22% 109
2022
Q4 		$4.54M Sell
82,318
-23,809
-22% -$1.31M 0.26% 91
2022
Q3 		$4.7M Sell
106,127
-1,411
-1% -$68.8K 0.27% 91
2022
Q2 		$5.25M Sell
107,538
-16,144
-13% -$727K 0.25% 82
2022
Q1 		$6.02M Sell
123,682
-13,964
-10% -$570K 0.24% 84
2021
Q4 		$5.87M Sell
137,646
-1,568
-1% -$62.5K 0.21% 94
2021
Q3 		$5.34M Sell
139,214
-1,224
-0.9% -$39.4K 0.2% 91
2021
Q2 		$3.96M Sell
140,438
-6,467
-4% -$194K 0.14% 109
2021
Q1 		$4.85M Buy
146,905
+112,630
+329% +$3.95M 0.16% 116
2020
Q4 		$1.24M Buy
+34,275
New +$1.38M 0.04% 237

Other funds holding HRMY

BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
Fidelity Investments
Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return
Dimensional Fund Advisors
Dimensional Fund Advisors Austin, Texas $481B AUM 30.42% 1-Year Est. Return
American Century Companies
American Century Companies Kansas City, Missouri $194B AUM 35% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
LSV Asset Management
LSV Asset Management Chicago, Illinois $46.4B AUM 27.74% 1-Year Est. Return
Arrowstreet Capital
Arrowstreet Capital Boston, Massachusetts $185B AUM 39.58% 1-Year Est. Return
VM
Valor Management Chicago, Illinois $181M AUM 6.67% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return

Rice Hall James & Associates's HRMY Position: Q3 2025 in Review

Rice Hall James & Associates sold out of Harmony Biosciences (HRMY) in Q3 2025, closing a stake of 76,287 shares — an estimated $2.41M sold.

Rice Hall James & Associates first reported a position in HRMY in Q4 2020 and held it in 19 quarters. The position peaked at $6.02M in Q1 2022. 296 funds tracked by Wall St. Rank hold HRMY as of Q3 2025.

  • Rice Hall James & Associates reported no remaining Harmony Biosciences position as of Q3 2025 after selling out during the quarter.
  • Rice Hall James & Associates sold 76,287 Harmony Biosciences shares in Q3 2025, an estimated $2.41M.
  • Rice Hall James & Associates first reported a position in Harmony Biosciences in Q4 2020 and held it in 19 quarters.
  • Rice Hall James & Associates's Harmony Biosciences position peaked at $6.02M in Q1 2022.
  • 296 funds tracked by Wall St. Rank held Harmony Biosciences as of Q3 2025.

Based on Rice Hall James & Associates's 13F filing for Q3 2025, filed 16 Oct 2025.